Ted Witek
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Ted Witek
Non-Executive Director / AFT Pharmaceuticals
Dr Ted Witek has over three decades of international clinical development and leadership experience.
Between 2014 and 2018, Dr Witek was senior vice president of corporate partnerships and chief scientific officer of Innoviva in San Francisco. Prior to that, he spent more than two decades, mainly in the US, with Boehringer Ingelheim where he rose to the role of president and chief executive of the multinational's Canadian and Portuguese operations.
Dr Witek has also served on the boards of numerous professional societies including Canada's Research-Based Pharmaceutical Companies (Rx&D) and the Drug/Device Discovery and Development Committee of the American Thoracic Society.
He has also served on the boards of numerous advisory organisations and companies including the Government of Ontario Health Innovation Council, Columbia University Health and Innovation Technology Lab, Lumira Ventures and Trudell Medical International.
Dr Witek has authored more than 100 scientific publications in the fields of respiratory health, public health, airway disease, and drug development. He is also a reviewer for numerous scientific journals.
Between 2014 and 2018, Dr Witek was senior vice president of corporate partnerships and chief scientific officer of Innoviva in San Francisco. Prior to that, he spent more than two decades, mainly in the US, with Boehringer Ingelheim where he rose to the role of president and chief executive of the multinational's Canadian and Portuguese operations.
Dr Witek has also served on the boards of numerous professional societies including Canada's Research-Based Pharmaceutical Companies (Rx&D) and the Drug/Device Discovery and Development Committee of the American Thoracic Society.
He has also served on the boards of numerous advisory organisations and companies including the Government of Ontario Health Innovation Council, Columbia University Health and Innovation Technology Lab, Lumira Ventures and Trudell Medical International.
Dr Witek has authored more than 100 scientific publications in the fields of respiratory health, public health, airway disease, and drug development. He is also a reviewer for numerous scientific journals.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 378th | Countplus | 22% | 8% |
| 435th | MedAdvisor | 17% | 3% |
| 795th | AFT Pharmaceuticals | -4% | 9% |
| 1578th | Betmakers Technology Group | -57% | 22% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 389th |  | AFT Pharmaceuticals | $145.7m |
| 458th | | MedAdvisor | $98.0m |
| 459th | | Countplus | $96.3m |
| 461st | | Betmakers Technology Group | $96.2m |
| 462nd | | Webcentral Group | $96.2m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Director, AFT Pharmaceuticals | 17 Jan 2021 |
